XML 92 R83.htm IDEA: XBRL DOCUMENT v3.22.2
Contingencies (Details) - USD ($)
$ / shares in Units, shares in Millions
1 Months Ended 12 Months Ended
Jul. 31, 2017
Feb. 28, 2022
Aug. 31, 2021
Feb. 28, 2021
Mar. 26, 2019
Contingencies (Details) [Line Items]          
Accrued salary and related charges       $ 2,704,000  
Principal amount and accrued interest   $ 4,000,000 $ 330,000    
Settlement amount $ 13,000,000 $ 108,400      
Maturity date   Sep. 01, 2022      
Remaining balance   $ 221,600      
Percentage of accrues interest   10.00%      
Warrants exercised (in Shares) 23.0        
Warrants exercisable term 7 years        
Warrants per share (in Dollars per share) $ 0.1        
Description of loan fees and late payment Under the terms of the settlement, we have agreed to pay an aggregate amount of $10 million over a period of seven years; $3 million of which is to be paid on or before June 8, 2022, after which, interest will accrue on the unpaid balance at a rate of 6%, compounded annually. All amounts, including all accrued interest, are to be paid no later than eight years from the date of the initial payment. The Kopple Parties have also received seven-year warrants to purchase up to an aggregate of approximately 3.3 million shares of our common stock at a price of $0.85 per share. The settlement also provides for standard mutual general release provisions and includes customary representations, warranties, and covenants, including certain increases in the amount payable to the Kopple Parties and the right of such parties to enter judgment against the Company if the Company remains in uncured default in its payment obligations under the settlement. As of June 8, 2022 and the date of this report, the Company has not yet paid the $3,000,000 installment due to Kopple. Pursuant to the agreement, the Company has 60 days to cure the nonpayment of the $3,000,000 default.        
Stanton Facility [Member]          
Contingencies (Details) [Line Items]          
Accrued salary and related charges   $ 238,000      
Director [Member]          
Contingencies (Details) [Line Items]          
Shares issued (in Shares)         27.5